Oral cyclophosphamide-induced posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis: A case report

doi:10.12998/wjcc.v9.i21.6130

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3527)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

302

WORD

158

HTML

1699

Figures (1-3)

237

Tables (1-1)

195

Sum=2591

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

367

Download

569

Sum=936

Jul 26, 2021 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jul 26, 2021; 9(21): 6130-6137
Published online Jul 26, 2021. doi: 10.12998/wjcc.v9.i21.6130

Full Size Figure Download Figure

Figure 3 Clinical course.

Citation: Kim Y, Kwak J, Jung S, Lee S, Jang HN, Cho HS, Chang SH, Kim HJ. Oral cyclophosphamide-induced posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis: A case report. World J Clin Cases 2021; 9(21): 6130-6137
URL: https://www.wjgnet.com/2307-8960/full/v9/i21/6130.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i21.6130